Objectives: To evaluate implant survival following primary total hip replacement (THR) in younger patients. To describe the diversity in use of cup-stem implant combinations. Design: 29,558 primary THRs osteoarthritis (OA) patients younger than 55 years of age performed from 1995 through 2011 were identified using the Nordic Arthroplasty Registry Association database. We estimated adjusted relative risk (aRR) of revision with 95% confidence interval (CI) using Cox regression. Results: In general, no difference was observed between uncemented and cemented implants in terms of risk of any revision. Hybrid implants were associated with higher risk of any revision (aRR ¼ 1.3, CI: 1.1 e1.5). Uncemented implants led to a reduced risk of revision due to aseptic loosening (aRR ¼ 0.5, CI: 0.5 e0.6), whereas the risk was similar for hybrid and cemented implants. Compared with cemented implants, both uncemented and hybrid implants led to elevated risk of revision due to other causes, as well as elevated risk of revision due to any reason within 2 years. 183 different uncemented cup-stem implant combinations were registered in Denmark, of these, 172 were used in less than 100 operations which is similar to Norway, Sweden and Finland. Conclusions: Uncemented implants perform better in relation to long-term risk of aseptic loosening, whereas both uncemented and hybrid rather than cemented implants in patients younger than 55 years had more short-term revisions because problems due to dislocation, periprosthetic fracture and infection has not yet been completely solved. The vast majority of cup-stem combinations were used in very few operations.
Introduction
Previous literature has shown the short-term and long-term risk of revision following primary total hip replacement (THR) to be higher in younger than in older patients 1e3 . These findings could be explained by significant decrease in body-weight and physical activity with age 4, 5 . In addition, secondary osteoarthritis (OA), common indication for THR in younger patients is associated with an elevated risk of revision during the first 6 postoperative months 1,6e 8 but also 10 years after primary THR. However, after adjustment for fixation technique no difference in implant survival was found between these two groups 6 . In general, most studies 3, 9 report an association between uncemented fixation and higher risk of revision. However, good results in terms of implant survival have been reported for uncemented implants in younger patients in some 10, 11 , but not all studies 12 . Still, it is unknown whether the change in design and materials over the last many years have influenced the risk of revision of uncemented implants, which have more often than cemented implants been subject to these changes. For instance, metal-on-metal bearing couples, which are known to have an increased risk of early revision 13 , have almost solely been used in uncemented implants. Large between-country variation in implants use 14 has been reported previously in NARA settings. Data from Australian hip and knee registry showed that only about 23% of the new introduced hip and knee implants were used in more than 100 procedures 15 in total, indicating further that the introduction of new implants is associated with worse outcome 15, 16 .
As only 5% of THRs are performed in patients younger than 55 years of age, it is difficult to get a sample size with adequate power from a single center or even from a single national arthroplasty registry. In 2007, The Nordic Arthroplasty Register Association (NARA) was established including selected variables, which population-based Danish, Norwegian, and Swedish hip registries could deliver. In 2010, the Finnish Hip Register joined NARA. The NARA database opened up new possibilities of studying the results of prosthetic concepts on a much larger scale than within any of the national registries.
The aim of this study was to evaluate the association between type of fixation and risk of revision following primary THR in patients younger than 55 years of age using the large populationbased NARA dataset. In addition, we aimed to describe the diversity in use of cup-stem implant combinations.
Methods

Study settings
We conducted a population-based follow-up study, based on data from prospective, nationwide hip arthroplasty registries in Sweden, Norway, Denmark and Finland. These four registries contain data on primary THRs and revisions performed in Sweden, Norway, Denmark and Finland since 1979, 1987, 1995 and 1980 , respectively. The registries are all validated and contain more than 90% of all THRs performed in each country 17e19 . All orthopedic departments in the respective countries, including private hospitals, provide pre-and peri-operative data on primary THR and revision procedures to these registries. All Swedish, Norwegian, Danish and Finnish citizens are assigned a unique civil registration number, permitting unambiguous linkage between hip registries and civil registration systems in each country, enabling tracking of patients who died, or emigrated.
The steering committees of the respective registries established the NARA in order to combine data in one Nordic hip arthroplasty database 14 .
Study population
The study included only patients younger than 55 years of age at the time of primary THR (n ¼ 58,493). THR on patients less than 35 years of age (n ¼ 4150) were excluded due to their low number and special reasons for requiring THR. Since previous studies found large discrepancy related to biology, treatment and prognosis 1, 20 between THR patients operated due to primary and secondary OA, we only focused on primary OA (thus n ¼ 20,769 THRs due to secondary OA was excluded). This also enhanced the possibility of comparing results with previous studies. Hip resurfacing procedures (n ¼ 4016) were also excluded from our study due to prognosis which is different from the prognosis of conventional THR 21 . After the exclusions, we identified 29,558 primary THRs performed between 1 January 1995 and 31 December 2011, including 3974 patients with bilateral surgery. Although assumption about independent observations is not fulfilled when bilateral observations are included in the analysis and this may theoretically have influence on the validity of the results, we choose to do so since this has not been shown to be a practical problem for analyses of arthroplasty register data 22, 23 .
Study outcome
The outcome measure was time to revision. Revision was defined as a new surgical intervention involving partial or complete exchange or removal of the implant. Data on primary THR and subsequent revision were accurately linked by the patient's unique civil registration number and the laterality of the hip registered in the country specific hip registries. Thus, the NARA database includes information on all first time revisions performed on the each identified primary THR patients irrespective of laterality during the follow-up period. We analyzed the risk of revision due to four reasons (1) any reason, (2) aseptic loosening, (3) other causes than aseptic loosening, and (4) any cause within 2 years of primary THR.
Statistical analyses
Age, sex, fixation technique, and calendar year of primary THR surgery were included in the analyses as possible risk factors. Follow-up began on the day of primary THR and ended on the day of first revision, on the day of death, emigration, or 31 December 2011, whichever came first. KaplaneMeier (KM) analyses were used to estimate the cumulative implant survival probabilities with standard error (SE) for survival. A Cox proportional hazards analysis was used to assess the risk of revision by computing hazard ratios (HR) as a measure of relative risks (RR) for revision with 95% Confidence Interval (CI). We compared uncemented, hybrid and inverse hybrid implant with cemented implants as reference group during the entire period 1995e2011 in relation to four outcomes previously described. We repeated these analyses for each of the following time periods, 1995e1999, 2000e2003, 2004e2007 and 2008e2011. In addition, we compared fixation techniques calculating the 5 years revision risk for patients with full 5 years follow up and 10 years revision risk accordingly. Since the fixation technique did not fulfill the proportional hazard assumption, we split the follow-up period into 1 year intervals. Separate sub-analyses were carried out for sub-study population 2002e2011 (n ¼ 19,282). The reason for doing so was to be able to account for femoral head size and different bearing surfaces as a confounding variable, as it has only been available in the NARA since 2002. We also presented the most commonly used cup-stem combinations separately for each type of fixation. As for the uncemented most common cup-stem combinations, we included those used in more than 3% of patients receiving uncemented implants. The corresponding percentage for other types of fixation was 4%. All analyses were performed using SAS version 9.1.3. (SAS Institute Inc, Cary, NC).
Results
Description of study population
Characteristics of the study population 1995e2011 are presented in Table I , including the distribution of causes for revision during the entire follow-up period (most common cause was aseptic loosening, followed by unspecified causes and dislocation), as well as within 2 years of primary THR (most common cause was dislocation, followed by aseptic loosening and deep infection). During the entire follow-up period, 8.2% (2413) of the primary THRs were revised due to any reason, whereas 4.4% (1290) and 3.8% (1123) were revised due to aseptic loosening and due to other reasons than aseptic loosening, respectively. 2.0% (590) of primary THRs were revised within the first 2 years due to any reason (Table I) .
Sub-study population 2002e2011 comprise of the following femoral head size: 28 mm (55%), 28e36 mm (29%), >36 mm (19%) and missing data (1%). About 60% of uncemented and 11% of cemented implants were inserted with femoral head size 28 mm. In total, following bearing surfaces were used: Metal-on-metal (14%), Metal-on-poly (45%), Ceramic-on-poly (20%), other surfaces (13%) and missing data (8%). For uncemented implants, the distribution was as following: 18%, 36%, 16% and 17%, whereas for cemented was 2%, 71%, 21% and 2%.
Fixation technique
During the entire study period of 1995e2011, we found no major difference between uncemented and cemented fixation in terms of risk of any revision ( Fig. 1(A) ). However, we found that uncemented implants were associated with a reduced risk of revision due to aseptic loosening (RR ¼ 0.5, CI: 0.5e0.6), but an elevated risk of revision due to other causes than aseptic loosening of 2.6 (CI: 2.2e 3.
2) compared to cemented implants (Table II) ( Fig. 1(B,C) ). In addition, risk of revision due to any cause within 2 years of surgery was almost twice as high for uncemented compared to cemented implants (RR ¼ 1.8, CI: 1.4e2.3) ( Fig. 1(D) ). Hybrid fixation technique was associated with 34% (CI: 1.2e1.5) higher risk of any revision compared with the cemented technique during the period 1995e2011. No difference was observed between hybrid and cemented implants in relation to revision due to aseptic loosening, but hybrid implants led to an increased risk of revision of 2.1 (CI: 1.7e2.6) due to other causes than aseptic loosening compared with cemented implants (Table II) . In addition, hybrid implants led to 65% higher risk of revision due to any cause within 2 years of surgery compared with cemented implants (CI: 1.2e2.3). We observed a tendency towards lower risk of any revision and revision due to aseptic loosening for inverse hybrid implants compared with cemented implants, but higher risk of other revisions (Table II) . The estimates did not differ between female and males, either between age groups 35e45 and 46e55 years of age.
Adjustment for the femoral head size and bearing surfaces, in addition to age, gender and calendar year of surgery in the separate analyses for the patients operated between 2002 and 2011 weakened the associations, but did not change substantially risk estimates when comparing fixation technique in relation to different revision outcomes (data not shown).
Supplementary appendix Table 1 present by gender and age groups the adjusted RR estimates with 95% CI for uncemented, hybrid and inverse hybrid implant with cemented implant as the reference group. The estimates did not deviate from the overall estimates for fixation techniques.
Fixation technique e time trend analyses
Results regarding fixation technique varied slightly through the four time periods. No difference was seen in the risk of any revision between uncemented and cemented implants when analyzing the data separately for each of the four different time periods [ Fig. 2(A) ]. Lower risk of revision due to aseptic loosening, increased risk of revision due to other causes than aseptic loosening, and increased risk of revision due to any cause within 2 years of primary surgery for uncemented compared with cemented implants was only evident in the periods 1995e1999 We presented crude KM survival data after 2, 10 and 16 years for different implants in relation to any revision, revision due to aseptic loosening and revision due to other causes than aseptic loosening in Table III. Supplementary appendix Table 2 present RR estimates for fixation technique according to follow-up period divided into 1 year intervals, indicating the same pattern regarding risk for revisions as observed in the four time periods.
Additional analyses of the 5 year and 10 years risk of any revision, revision due to aseptic loosening and revision due to other causes than aseptic loosening among patients with complete 5 and 10 years follow up are presented in Table IV . Again, uncemented implants had the same or increased risk of any revision compared with cemented implants, reduced risk of revision due to aseptic loosening and increased risk of revision due to other causes. Revision risk for hybrid and inverse hybrid implants compared with cemented has not changed substantially from the estimates presented in Table II .
Implant brands
Four types of uncemented implants were accounting for 30% of all uncemented THRs (thus, 3675 patients received the four most common uncemented implants, whereas 11,021 patients received other uncemented implants) (Table V) . Likewise, 4041 (61%), 720 (27%) and 1043 (36%) patients received the four most common cemented, hybrid and inverse hybrid cup-stem implants, respectively. During the entire study period 1995e2011, 183 different uncemented cup-stem combinations were registered in Denmark and 94% were used in less than 100 operations. Similarly, in Norway, Sweden and Finland, 95%, 91%, and 94% uncemented combinations were used in less than 100 operations during the entire study period. The similar picture was seen for cemented cup-stem combinations in all four countries. 60 combinations were used in less than 100 operations. Likewise, in Norway, Sweden and Finland, 65 out of 69, 95 out of 106, and 73 out of 74 cemented combinations were used in less than 100 operations during the entire study period.
Discussion
Study population
More than half of our study population received uncemented implants, with between-countries variations from 37% to 84%. This is in agreement with the latest review of annual report data from seven international hip replacement registries, showing a current prevalence of uncemented implants among all THR patients of between 15% and 82% 24 . Uncemented implants, in particular the modern second-generation type, have been the first choice of implant for younger patients, whereas cemented implants were more commonly used in older patients 25e29 . Some countries, however, including Australia, Denmark, Finland and Canada predominantly use uncemented implants irrespective of patient age 25, 28, 30 . The increase in use of uncemented implants has been reported in all age groups, including older patients, despite reports showing that survival of cemented implants is clearly better than uncemented implants among patients older than 75 years of age 12 and patients older than 65 years of age 31 . The recommendation on use of fixation technique should be further guided by the mortality risk which was found to be different between cemented and uncemented implants 32 .
Fixation technique
Our analyses show that the risk of any revision related to uncemented implants was comparable to that of cemented implants, which confirms the recent findings from several registries including those of New Zealand, Sweden, Finland, England, Norway and Denmark 11, 12, 26, 28, 33, 34 . Some of the uncemented implants introduced in Norway before 2000 were found to have higher overall risk of revision than cemented implants 33 and were consequently removed from the market. A systematic review and meta-analysis of nine randomized trials, including a total of 930 THRs with a mean age of 60 years also confirmed that there is no major difference between uncemented and cemented implants in relation to risk of any revision 35 . Results from the Australian Hip Registry 36 show also no difference between uncemented and cemented implants in relation to any revision, which change to significantly lower risk of revision in uncemented implants after exclusion of large head size. Adjusting for head size, we were not able to achieve the same results. Uncemented implants were introduced in order to solve the problem of aseptic loosening of cemented implants 37 as well as wear of the acetabular bearing side 38 , particularly in younger patients. Our study document both 5 and 10 years lower risk of revision due to aseptic loosening for uncemented vs cemented implants, which is in agreement with previous findings 11, 28, 34 . The risk estimates for the period 2008e 2011 presented in Fig. 2 (B) in relation to aseptic loosening are affected by high uncertainty (since the aseptic loosening occurs after a longer follow-up period) and should be interpreted with caution.
Uncemented implants may be more resistant to aseptic loosening but are more susceptible to revisions due to other causes, including dislocations, fractures and infections. The differences in the femoral head size and bearing surfaces used between cemented and uncemented implants could not entire explain the association we found. On the other hand, the potential difference in the use of cross-linked poly liner with documented low revision rate due to wear 39 between fixation types may affect our results. Unfortunately, information on highly cross-linked polyethylene use was not available in our dataset. The analyses from New Zealand showed a higher revision rate for uncemented vs cemented implants among all THR patients more than 90 days postoperatively due to dislocations, pain, periprosthetic femoral fractures and other causes, except deep infections 11 . Separate data on younger patients were not available in their study. Another study from Finland on patients less than 55 years of age found more dislocations, fractures and revisions due to other reasons in uncemented than cemented THRs 34 , in addition to higher wear of the polyethylene liner among modular uncemented cups. A study based on Swedish data from the period 1992e2007 found an increased fracture risk around uncemented stems compared to cemented stems 12 . The increase in early revision risk due to dislocations, fractures and deep infections has been observed in many countries 26e28 . Several risk factors for dislocation have been identified including small femoral head size 40, 41 and posterior surgical approach 42 . Further research is warranted to increase our understanding of the risk factors for dislocations, fractures and deep infections. However, integration of clinical expertise and evidence-based medicine including national hip registry data into the decision-making process for patient care to optimize clinical outcome remains a challenge. However, our findings presented in Fig. 2(D) of no major difference in the risk of revision due to any cause within 2 years of surgery in the latest time period when comparing different fixation types might be promising. Still, there is a lot of work to be done to overcome short-term problems of uncemented implants. A recent study, however, found that uncemented implants are still associated with low cost effectiveness when comparing improvement in health related outcomes 43 .
Despite longer tradition of use of hybrid implant, a New Zealand study among younger patients found comparable survival of hybrid implants and cemented implants in relation to revision due to aseptic loosening 11 , which is similar to our results. The results are also found in the Australian hip registry 36 . Hybrid implants were also in our study more susceptible to revision causes other than aseptic loosening, may be because of problems related to the uncemented cup component. The problem is not only short-term, since analyses among patients with complete 5 and 10 years follow up pointed up in the same direction. The slightly higher revision risk of on inverse hybrid compared with cemented was also related to other revision than aseptic loosening. This finding accords with previous reports of increased risk of early periprosthetic fractures and infections using inverse hybrid implants 44, 45 .
Implants brands
Another interesting but concerning finding in our study is the fact that about 70% of the THR patients received more than 100 different uncemented cup-stem implant combinations rather than one of the most common combinations presented in Table III . It is worrisome that the majority of combinations available on the market have only been used in less than 100 operations during the 17 years long study period. Other registries reported that more than 70% of their new introduced implants was used in less than 100 cases which is a problem since about 30% of these implants had higher revision rate compared to well established implants in the same class and none of the implants performed better 15, 16 . Low number of observations and few revisions hampers conclusive analyses of single combinations. The clinicians are familiar with parts of the health technology assessment process in the context of the introduction of new drugs and the phases I to IV of drug trial development 46 . However, the assessment of novel surgical devices has not quite reached the level of pharmacological trials. More than two decades ago, stepwise introduction of new hip implants was introduced with growing acceptance, including clinical trials, radiostereometry, digitized radiography and a national hip registry 47 . One may argue that implants used in a small number of operations are in phase IV of a stepwise introduction. In addition, the introduction of new implants involves aspects not known in drug trials, such as surgeons needing to acquire new practical skills and go through a "learning curve", efficacy vs effectiveness issues, and cost-benefit assessments of implants. The number of different surgeons using specific implants and surgeon volume is variables further needed to fully understand the size of the problem. However, it has been shown previously that low hospital volume affect more survival of uncemented than cemented implants 48 which might be an extra argument for using cemented implants since they are not so prone to technical error. The high number of implant combinations on the market makes novelty of new implants questionable. The validity of implant brands and combinations reported to NARA is not fully known as only three of the four registries in NARA are using the catalog numbers to identify the implants. This system, when fully implemented would in future enable uniformly identification and comparison of implant withinand between countries.
Methodological considerations
We used the NARA dataset, which includes registry data from four Scandinavian countries with well-documented registration completeness and data validity 17e19 . By using the NARA database we were able to obtain a sufficient number of patients to get reliable risk estimates for revision. Still, we were not able to perform detailed analyses on different implant brands and combinations. Although we performed multivariate analyses controlling for some confounders we cannot entirely exclude the impact of bias on our estimates. For example, we did not have information on surgeon volume which might explain some of our findings in relation to higher early revision rates of uncemented and hybrid implants. However, this information has merely been available in previous studies on the same subject. Although patient and surgeon preferences may be related to age and sex 49 , we have no reason to believe that these preferences are related to fixation technique in this young patient population. The assumption of proportional hazard was not fulfilled in Cox regression analyses for fixation technique which we partly dealt with splitting the follow-up period. However we still reported the overall RR estimates being very well aware that our risk estimates might be biased in order to be able to compare our results with the results from other registries using the same method.
In conclusion, in this large population-based study on younger THR patients, risk of any revision was similar for uncemented and cemented implants whereas it was higher for hybrid implants. Uncemented implants perform better in relation to long-term risk of aseptic loosening, whereas both uncemented and hybrid rather than cemented implants in patients younger than 55 years had more short-term revisions because problems due to dislocation, periprosthetic fracture and infection has not yet been completely solved. The vast majority of implant combinations were used in very few operations.
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